AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29316905 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-app intervention for 12 weeks
Number of subjects: 250
Study 29316905 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 250
Study 28776413 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong program (60 minutes)
Number of subjects: 26
Study 26069178 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel, Cisplatin, and 5‐FU (TPF) induction chemotherapy followed by surgery
Number of subjects: 24
Study 26069178 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 24
Study 23380383 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-CT fusion-based sector analysis
Number of subjects: 50
Study 23380383 — intervention group
Group type: COMPARATOR
Intervention: CT scans
Number of subjects: 50
Study 21910821 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.5 mg/kg body weight)
Number of subjects: 210
Study 21910821 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (60 units/kg body weight)
Number of subjects: 210
Study 21910821 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (60 units/kg body weight) with concomitant use of acetylsalicylic acid (ASA)
Number of subjects: 210
Study 19127909 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziwu Liuzhu group
Number of subjects: 2
Study 19127909 — intervention group
Group type: COMPARATOR
Intervention: Channel acupoint selection group
Number of subjects: 2
Study 19127909 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Ziwu Liuzhu group and Channel acupoint selection group
Number of subjects: 2
Study 16457909 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonston-Zagreb (EZ) HTMV
Number of subjects: 1533
Study 16457909 — intervention group
Group type: EXPERIMENTAL
Intervention: Connaught HTMV
Number of subjects: 1533
Study 16457909 — intervention group
Group type: EXPERIMENTAL
Intervention: HTMV without DTP
Number of subjects: 1533
Study 16457909 — intervention group
Group type: COMPARATOR
Intervention: HTMV with DTP
Number of subjects: 1533
Study 16457909 — intervention group
Group type: COMPARATOR
Intervention: EZ HTMV
Number of subjects: 1533
Study 16457909 — intervention group
Group type: EXPERIMENTAL
Intervention: HTMV without further DTP doses
Number of subjects: 1533
Study 12629336 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination pneumatic/ultrasonic lithotrite
Number of subjects: 20
Study 12629336 — intervention group
Group type: COMPARATOR
Intervention: Standard ultrasonic device
Number of subjects: 20
Study 10997757 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive measures (four different programs)
Number of subjects: 3373
Study 9075663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (750 mg/day) and endoscopic dilation of major duct stenoses
Number of subjects: 65
Study 8245999 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented fixation of the tibial component
Number of subjects: 34
Study 8245999 — intervention group
Group type: COMPARATOR
Intervention: Cemented fixation of the tibial component
Number of subjects: 34
Study 3527809 — intervention group
Group type: COMPARATOR
Intervention: 30 mg/kg i.v. dose of methylprednisolone sodium succinate (MPSS) followed by an identical dose three hours later in Study Group 2.
Number of subjects: 849
Study 31654312 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone (DRSP) containing oral contraceptives (3 mg DRSP/30 mcg EE)
Number of subjects: 120
Study 31654312 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormadinone acetate (CMA) containing oral contraceptives (2 mg CMA/30 mcg EE)
Number of subjects: 120
Study 29502087 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention group attended an antenatal diabetes clinic, commenced daily home blood glucose monitoring, and medication prescribed if lifestyle measures failed.
Number of subjects: 0
Study 29502087 — intervention group
Group type: COMPARATOR
Intervention: Standard care with lifestyle education and a 75 g oral glucose tolerance test at 24 weeks' gestation.
Number of subjects: 0
Study 29502087 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 29502087 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention group
Number of subjects: 0
Study 26139491 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiomesh/Securestrap (PH)
Number of subjects: 100
Study 26139491 — intervention group
Group type: COMPARATOR
Intervention: Ventralight ST/SorbaFix (VS)
Number of subjects: 100
Study 24576877 — intervention group
Group type: EXPERIMENTAL
Intervention: Macular GCIPL parameters (inferotemporal sector)
Number of subjects: 184
Study 24576877 — intervention group
Group type: COMPARATOR
Intervention: Peripapillary RNFL parameters (7 o'clock sector)
Number of subjects: 184
Study 24576877 — intervention group
Group type: COMPARATOR
Intervention: Optic nerve head parameters (rim area)
Number of subjects: 184
Study 23225821 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 84
Study 23225821 — intervention group
Group type: COMPARATOR
Intervention: Head-up tilt position
Number of subjects: 84
Study 21999637 — intervention group
Group type: EXPERIMENTAL
Intervention: TELEmonitoring device for medication adherence support used for six months in addition to usual care.
Number of subjects: 400
Study 21999637 — intervention group
Group type: COMPARATOR
Intervention: Usual care arm (control group).
Number of subjects: 400
Study 21999637 — intervention group
Group type: EXPERIMENTAL
Intervention: TELEmonitoring device for medication adherence support.
Number of subjects: 400
Study 18488807 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of spironolactone (100 mg)
Number of subjects: 20
Study 18488807 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of spironolactone (100 mg)
Number of subjects: 20
Study 18488807 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of canrenone (active metabolite)
Number of subjects: 20
Study 18488807 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of canrenone (active metabolite)
Number of subjects: 20
Study 18488807 — intervention group
Group type: EXPERIMENTAL
Intervention: Test and Reference formulations
Number of subjects: 20
Study 17726806 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 400 micrograms every 4 hours until termination of pregnancy
Number of subjects: 138
Study 17726806 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol 400 micrograms every 4 hours until termination of pregnancy
Number of subjects: 138
Study 14739713 — intervention group
Group type: EXPERIMENTAL
Intervention: Class I antiarrhythmic drugs
Number of subjects: 13858
Study 14739713 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 13858
Study 14739713 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 13858
Study 14739713 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical cardioversion
Number of subjects: 13858
Study 14739713 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without AF)
Number of subjects: 13858
Study 10896376 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental bandage system (Warm‐Up; Augustine Medical Inc, Eden Prairie, Minn)
Number of subjects: 40
Study 10896376 — intervention group
Group type: COMPARATOR
Intervention: Conventional elastic bandage (Medipore Dress‐it; 3M, St Paul, Minn)
Number of subjects: 40
Study 8881094 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 48
Study 8881094 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based exposure treatment
Number of subjects: 48
Study 8881094 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cognitive/performance treatment
Number of subjects: 48
Study 8881094 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 48
Study 1555416 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen administration during apneas
Number of subjects: 6
Study 1555416 — intervention group
Group type: COMPARATOR
Intervention: Breathing room air
Number of subjects: 6
Study 1555416 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen administration
Number of subjects: 6
Study 3427251 — intervention group
Group type: EXPERIMENTAL
Intervention: Full contextual detail about the respondent and the event
Number of subjects: 48
Study 3427251 — intervention group
Group type: COMPARATOR
Intervention: Edited version with only a basic outline of the event
Number of subjects: 48
Study 29161376 — intervention group
Group type: EXPERIMENTAL
Intervention: One-phase treatment group (fixed appliance only)
Number of subjects: 74
Study 29161376 — intervention group
Group type: COMPARATOR
Intervention: Two-phase treatment group (removable appliance before fixed appliance)
Number of subjects: 74
Study 29161376 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (boys)
Number of subjects: 74
Study 29161376 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (patients with agenesis)
Number of subjects: 74
Study 29071932 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalamin (1 mL) injection
Number of subjects: 90
Study 29071932 — intervention group
Group type: EXPERIMENTAL
Intervention: Gangliosides (1 mL) injection
Number of subjects: 90
Study 29071932 — intervention group
Group type: COMPARATOR
Intervention: Routine medication and rehabilitation training (Control)
Number of subjects: 90
Study 24990160 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (12 treatments over 8 weeks, twice weekly for 4 weeks then once weekly for 4 weeks)
Number of subjects: 20
Study 24990160 — intervention group
Group type: COMPARATOR
Intervention: Control (treatment as usual)
Number of subjects: 20
Study 22630807 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR self-monitoring (24-week program)
Number of subjects: 185
Study 22630807 — intervention group
Group type: COMPARATOR
Intervention: Control (assessment-only condition)
Number of subjects: 185
Study 19698041 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hydrocephalus group (10 patients)
Number of subjects: 32
Study 19698041 — intervention group
Group type: COMPARATOR
Intervention: Atrophy group (8 patients)
Number of subjects: 32
Study 19698041 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (14 volunteers)
Number of subjects: 32
Study 18243459 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention cued to high spatial frequencies (SFs)
Number of subjects: 0
Study 18243459 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention cued to low spatial frequencies (SFs)
Number of subjects: 0
Study 18243459 — intervention group
Group type: COMPARATOR
Intervention: Control experiments manipulating the width of the attentional window
Number of subjects: 0
Study 16321662 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 22
Study 16321662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 12728156 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (0.15 mg/kg 6 hourly for 48 hours)
Number of subjects: 82
Study 12728156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 10052766 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR+DFDBA (bioabsorbable barrier + demineralized freeze-dried bone allografts)
Number of subjects: 12
Study 10052766 — intervention group
Group type: COMPARATOR
Intervention: GTR (bioabsorbable barrier alone)
Number of subjects: 12
Study 10052766 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR+DFDBA
Number of subjects: 12
Study 10052766 — intervention group
Group type: COMPARATOR
Intervention: GTR
Number of subjects: 12
Study 10052766 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 12
Study 7566608 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal imaging techniques (sonography and either tomography or CT scan)
Number of subjects: 598
Study 7566608 — intervention group
Group type: COMPARATOR
Intervention: Daily use of analgesic mixtures for at least 5 years
Number of subjects: 598
Study 2292540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 140
Study 2292540 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin
Number of subjects: 140
Study 478543 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile and luminance degradation (four levels of luminance degradation and two levels of tactile restriction)
Number of subjects: 5
Study 478543 — intervention group
Group type: COMPARATOR
Intervention: Standardized U.S. Navy work task (control condition)
Number of subjects: 5
Study 31002283 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat therapy (spa bathing at ∼39°C, 3‐5 days/wk for ≤30 min, followed by ≤30 min of callisthenics)
Number of subjects: 22
Study 31002283 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise (≤90 min of supervised walking and gym‐based exercise, 1‐2 days/wk)
Number of subjects: 22
Study 28478854 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized preoperative stoma-education program
Number of subjects: 107
Study 25171662 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to BCRL self-care activities
Number of subjects: 128
Study 25171662 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to BCRL self-care modalities
Number of subjects: 128
Study 23583255 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training plus simvastatin (40 mg/day)
Number of subjects: 37
Study 23583255 — intervention group
Group type: COMPARATOR
Intervention: Exercise training only
Number of subjects: 37
Study 21778330 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg daily for 3 months)
Number of subjects: 73
Study 21778330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 19801948 — intervention group
Group type: EXPERIMENTAL
Intervention: L-asparaginase (L-asp) therapy, median 5.5 doses (range: 1 to 20 doses)
Number of subjects: 192
Study 19801948 — intervention group
Group type: EXPERIMENTAL
Intervention: L-asparaginase (L-asp) therapy
Number of subjects: 192
Study 19801948 — intervention group
Group type: COMPARATOR
Intervention: No L-asparaginase therapy (control group)
Number of subjects: 192
Study 19801948 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk chemotherapy regimen
Number of subjects: 192
Study 16679506 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometers
Number of subjects: 14
Study 16679506 — intervention group
Group type: COMPARATOR
Intervention: Footswitches
Number of subjects: 14
Study 15337213 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex aortic plaques (44 persons)
Number of subjects: 585
Study 15337213 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple aortic plaques (253 persons)
Number of subjects: 585
Study 15337213 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic atherosclerotic plaques (both simple and complex)
Number of subjects: 585
Study 11748517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 0.015 mg/kg
Number of subjects: 45
Study 11748517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 0.03 mg/kg
Number of subjects: 45
Study 11748517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 9269506 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with modified Phleum pratense allergenic extracts
Number of subjects: 10
Study 9269506 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with specific IT, only drugs)
Number of subjects: 10
Study 8302441 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal upright bicycle exercise followed by supine rest for 60 min
Number of subjects: 9
Study 8302441 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise (control) day with upright position for 30 min followed by 60 min supine
Number of subjects: 9
Study 3820353 — intervention group
Group type: EXPERIMENTAL
Intervention: Early massive excision of all full-thickness burns
Number of subjects: 50
Study 3820353 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 50
Study 28623465 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered Toothbrush (PT)
Number of subjects: 100
Study 28623465 — intervention group
Group type: COMPARATOR
Intervention: Manual Toothbrush (MT)
Number of subjects: 100
Study 28623465 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Toothbrushes (PT and MT)
Number of subjects: 100
Study 26524706 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 16492
Study 26524706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16492
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative CFR in group 1 (mild renal failure)
Number of subjects: 52
Study 24631986 — intervention group
Group type: COMPARATOR
Intervention: Preoperative CFR in group 2 (no renal failure)
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative CFR in group 1 (mild renal failure)
Number of subjects: 52
Study 24631986 — intervention group
Group type: COMPARATOR
Intervention: Postoperative CFR in group 2 (no renal failure)
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative creatinine clearance
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative estimated GFR
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative day 7 creatinine clearance
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative month 6 creatinine clearance
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative day 7 estimated GFR
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative month 6 estimated GFR
Number of subjects: 52
Study 24631986 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR change after bypass surgery
Number of subjects: 52
Study 24372434 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral injection of Bulkamid®
Number of subjects: 52
Study 20881485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 0
Study 20881485 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation
Number of subjects: 0
Study 20881485 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative exercise training regimens
Number of subjects: 0
Study 18455326 — intervention group
Group type: EXPERIMENTAL
Intervention: vdr-VMAT
Number of subjects: 10
Study 18455326 — intervention group
Group type: EXPERIMENTAL
Intervention: cdr-VMAT
Number of subjects: 10
Study 18455326 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 10
Study 18455326 — intervention group
Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 10
Study 16765428 — intervention group
Group type: EXPERIMENTAL
Intervention: Information on colorectal cancer risk factors
Number of subjects: 3185
Study 16765428 — intervention group
Group type: EXPERIMENTAL
Intervention: Information on risk factors and colorectal screening
Number of subjects: 3185
Study 16765428 — intervention group
Group type: COMPARATOR
Intervention: Control group (no information)
Number of subjects: 3185
Study 16765428 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 3185
Study 12586796 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 856
Study 12586796 — intervention group
Group type: COMPARATOR
Intervention: MOPP/ABV
Number of subjects: 856
Study 8734595 — intervention group
Group type: EXPERIMENTAL
Intervention: Talc coating on surfaces
Number of subjects: 10
Study 8734595 — intervention group
Group type: EXPERIMENTAL
Intervention: Water coating on surfaces
Number of subjects: 10
Study 8734595 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose coating on surfaces
Number of subjects: 10
Study 8734595 — intervention group
Group type: COMPARATOR
Intervention: Untreated smooth surface
Number of subjects: 10
Study 8734595 — intervention group
Group type: EXPERIMENTAL
Intervention: Textured surfaces (with coatings)
Number of subjects: 10
Study 1662595 — intervention group
Group type: COMPARATOR
Intervention: Nova T (Cu‐IUD)
Number of subjects: 168
Study 1662595 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic gestodene (OC)
Number of subjects: 168
Study 1662595 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly norethisterone enanthate 50 mg + estradiol valerate 5 mg (injectable)
Number of subjects: 168
Study 7114004 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin therapy (n = 13)
Number of subjects: 55
Study 7114004 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 17)
Number of subjects: 55
Study 30703494 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 63
Study 30703494 — intervention group
Group type: EXPERIMENTAL
Intervention: Fufang Danshen Dripping Pill (FDDP)
Number of subjects: 63
Study 30703494 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of clopidogrel and FDDP
Number of subjects: 63
Study 29663464 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg (30 mg for dose reduction)
Number of subjects: 560
Study 29663464 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKA)
Number of subjects: 560
Study 29663464 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging substudy
Number of subjects: 560
Study 26812902 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory training
Number of subjects: 81
Study 26812902 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing speed training
Number of subjects: 81
Study 26812902 — intervention group
Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 81
Study 24766750 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-alcohol-related postings on Facebook
Number of subjects: 1
Study 24766750 — intervention group
Group type: COMPARATOR
Intervention: Friends' alcohol-related postings on Facebook
Number of subjects: 1
Study 22005174 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation treatment (SCT)
Number of subjects: 528
Study 22005174 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 528
Study 20599140 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) before therapy sessions
Number of subjects: 0